14-0355 A multicenter, randomized,double-blind, placebo-controlled, 2 period crossover study to evaluate the efficacy and safety of BCX4161 for 12 weeks as an oral prophylaxis treatment for attacks of hereditary angioedema

  • Grant, J A (PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date4/17/15 → 4/16/17

Funding

  • Biocryst Pharmaceuticals, Inc.: $5,150.00